APA

Lehe C., Ghebeh H., Al-Sulaiman A., Al Qudaihi G., Al-Hussein K., Almohareb F., Chaudhri N., Alsharif F., Al-Zahrani H., Tbakhi A., Aljurf M. & Dermime S. (20080908). The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. : Cancer research.

Chicago

Lehe Cynthia, Ghebeh Hazem, Al-Sulaiman Abdullah, Al Qudaihi Ghofran, Al-Hussein Khaled, Almohareb Fahad, Chaudhri Naeem, Alsharif Fahad, Al-Zahrani Hazza, Tbakhi Abdelghani, Aljurf Mahmoud and Dermime Said. 20080908. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. : Cancer research.

Harvard

Lehe C., Ghebeh H., Al-Sulaiman A., Al Qudaihi G., Al-Hussein K., Almohareb F., Chaudhri N., Alsharif F., Al-Zahrani H., Tbakhi A., Aljurf M. and Dermime S. (20080908). The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. : Cancer research.

MLA

Lehe Cynthia, Ghebeh Hazem, Al-Sulaiman Abdullah, Al Qudaihi Ghofran, Al-Hussein Khaled, Almohareb Fahad, Chaudhri Naeem, Alsharif Fahad, Al-Zahrani Hazza, Tbakhi Abdelghani, Aljurf Mahmoud and Dermime Said. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. : Cancer research. 20080908.